News and Media

2015/07/02 – Quantum Genomics speeds its development work in the field of heart failure

2 July 2015
|

Quantum Genomics (Alternext – FR0011648971 – ALQGC), ), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, announces its intention to speed its research and development work on its QGC101 drug candidate for the prevention and […]

2015/06/29 – Quantum Genomics obtains positive results with heart failure study in dogs

29 June 2015
|

Quantum Genomics (Alternext – FR0011648971 – ALQGC), ), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, announces that the study for the prevention and treatment of heart failure in dogs has been completed within the […]

2015/06/02 – Quantum Genomics at the 2015 BIO International Convention, June 15-18 in Philadelphia, and at the French Life Sciences Days, June 17-18, 2015, in New York

2 June 2015
|

Quantum Genomics (Alternext – FR0011648971 – ALQGC), ), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, announces its participation in two major events in the US : 2015 BIO International Convention (Biotechnology Industry Organization […]

2015/04/22 – 2014 Annual financial report now available – Update on Q1 2015 activity

22 April 2015
|

Quantum Genomics (Alternext – FR0011648971 – ALQGC), ), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, announces that its 2014 annual financial report is available on its website, which includes the 2014 annual financial statements […]